Introduce and support the CLEAR LABELS Act to require country-of-origin labeling for prescription medicines.

Chairman Rick Scott and Ranking Member Kirsten Gillibrand highlighted their bipartisan CLEAR LABELS Act in an interview, emphasizing the need for country-of-origin labeling for prescription medicines to inform Americans about the origins of their medications.

Rick Scott committed to introducing and backing the CLEAR LABELS Act, which would require prescription medicines to be labeled with their country of origin.

IN CASE YOU MISSED IT… Chairman Scott, Ranking Member Gillibrand Push CLEAR LABELS Act to Label Foreign-Made Drugs
secondary · other · model gpt-4.1

The hearing emphasized the need for transparency and the importance of the CLEAR LABELS Act in addressing these concerns.

Rick Scott highlighted his commitment to increasing transparency in the U.S. medicine supply by stressing the importance of the CLEAR LABELS Act, which would require country-of-origin labeling for prescription medicines.

Chairman Rick Scott Exposes Communist China’s Dangerous Grip on America’s Medicine Supply; Highlights CLEAR LABELS Act to Increase Transparency
primary · other · model gpt-4.1

Senator Rick Scott introduced the CLEAR LABELS Act, aiming to add country-of-origin labeling requirements to the U.S. prescription drug supply chain.

Rick Scott commits to country-of-origin labeling for prescription drugs through the CLEAR LABELS Act.

Sen. Rick Scott Announces CLEAR LABELS Act to Hold Drug Manufacturers Accountable and Strengthen Supply Chain Oversight
primary · other · model gpt-4.1

Chairman Rick Scott’s bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act received bicameral support with Congressman Rich McCormick leading the effort in the House of Representatives.

The CLEAR LABELS Act, introduced by Senator Rick Scott, gained support in the House with Congressman Rich McCormick leading the effort, indicating progress in advancing the legislation.

partial same_term A for effort

Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House
primary · model gpt-4.1 · confidence 90%

Chairman Rick Scott led a hearing entitled “Foreign Dependence: How China Captured America’s Drug Supply” to examine how Communist China has pursued global dominance in pharmaceutical manufacturing and how America’s trade, regulatory, and procurement decisions have contributed to the decline of America’s domestic production capacity.

Senator Rick Scott chaired a hearing focusing on China's influence over America's drug supply, underscoring the need for the CLEAR LABELS Act to enhance transparency.

partial same_term A for effort

Chairman Rick Scott Exposes Communist China’s Dangerous Grip on America’s Medicine Supply; Highlights CLEAR LABELS Act to Increase Transparency
primary · model gpt-4.1 · confidence 90%

Chairman Rick Scott led a hearing entitled “Truth in Labeling: Americans Deserve to Know Where Their Drugs Come From,” in which he exposed the serious risks of America’s overreliance on foreign-manufactured, generic drugs and announced his CLEAR LABELS Act, legislation requiring country-of-origin labeling for prescription drugs in the United States.

Senator Rick Scott announced the CLEAR LABELS Act during a hearing addressing the risks of reliance on foreign-manufactured generic drugs, advocating for country-of-origin labeling.

partial same_term A for effort

Chairman Rick Scott Calls for Transparency of Foreign-Made Generic Drugs, Announces CLEAR LABELS Act to Require Country-of-Origin Labeling
primary · model gpt-4.1 · confidence 90%

U.S. Senators Kirsten Gillibrand (D-NY) and Rick Scott introduced legislation—the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act—to add country of origin labeling requirements to the U.S.’s prescription drug supply chain.

Senators Gillibrand and Scott introduced the CLEAR LABELS Act to mandate country-of-origin labeling for prescription drugs, aiming to enhance transparency in the pharmaceutical supply chain.

partial same_term A for effort

Gillibrand, Scott Introduce Legislation To Promote Drug Origin Transparency
primary · model gpt-4.1 · confidence 90%

U.S. Senator Tommy Tuberville (R-AL) joined U.S. Sen. Rick Scott (R-FL) in introducing the Consumers Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act to add country of origin labeling requirements to the United States’ prescription drug supply chain.

Senator Tommy Tuberville co-sponsored the CLEAR LABELS Act with Senator Rick Scott, supporting the initiative to require country-of-origin labeling for prescription drugs.

partial same_term A for effort

Tuberville Joins CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency
primary · model gpt-4.1 · confidence 90%